BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23737540)

  • 1. Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patients.
    Lukas C; Sombekke MH; Bellenberg B; Hahn HK; Popescu V; Bendfeldt K; Radue EW; Gass A; Borgwardt SJ; Kappos L; Naegelin Y; Knol DL; Polman CH; Geurts JJ; Barkhof F; Vrenken H
    Radiology; 2013 Nov; 269(2):542-52. PubMed ID: 23737540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis--a quantitative T1 relaxation time mapping approach.
    Vaithianathar L; Tench CR; Morgan PS; Constantinescu CS
    J Neurol; 2003 Mar; 250(3):307-15. PubMed ID: 12638021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of cervical spinal cord atrophy on quality of life in multiple sclerosis.
    Zurawski J; Glanz BI; Healy BC; Tauhid S; Khalid F; Chitnis T; Weiner HL; Bakshi R
    J Neurol Sci; 2019 Aug; 403():38-43. PubMed ID: 31207364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical Cord T1-weighted Hypointense Lesions at MR Imaging in Multiple Sclerosis: Relationship to Cord Atrophy and Disability.
    Valsasina P; Aboulwafa M; Preziosa P; Messina R; Falini A; Comi G; Filippi M; Rocca MA
    Radiology; 2018 Jul; 288(1):234-244. PubMed ID: 29664341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms.
    Nijeholt GJ; van Walderveen MA; Castelijns JA; van Waesberghe JH; Polman C; Scheltens P; Rosier PF; Jongen PJ; Barkhof F
    Brain; 1998 Apr; 121 ( Pt 4)():687-97. PubMed ID: 9577394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetization transfer ratio of the spinal cord in multiple sclerosis: relationship to atrophy and neurologic disability.
    Lycklama à Nijeholt GJ; Castelijns JA; Lazeron RH; van Waesberghe JH; Polman CH; Uitdehaag BM; Barkhof F
    J Neuroimaging; 2000 Apr; 10(2):67-72. PubMed ID: 10800258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normalized upper cervical spinal cord atrophy in multiple sclerosis.
    Song F; Huan Y; Yin H; Ge Y; Wei G; Chang Y; Zhao H
    J Neuroimaging; 2008 Jul; 18(3):320-7. PubMed ID: 18318794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis: hyperintense lesions in the brain on nonenhanced T1-weighted MR images evidenced as areas of T1 shortening.
    Janardhan V; Suri S; Bakshi R
    Radiology; 2007 Sep; 244(3):823-31. PubMed ID: 17690319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mean upper cervical cord area (MUCCA) measurement in long-standing multiple sclerosis: relation to brain findings and clinical disability.
    Daams M; Weiler F; Steenwijk MD; Hahn HK; Geurts JJ; Vrenken H; van Schijndel RA; Balk LJ; Tewarie PK; Tillema JM; Killestein J; Uitdehaag BM; Barkhof F
    Mult Scler; 2014 Dec; 20(14):1860-5. PubMed ID: 24812042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration.
    Kearney H; Rocca MA; Valsasina P; Balk L; Sastre-Garriga J; Reinhardt J; Ruggieri S; Rovira A; Stippich C; Kappos L; Sprenger T; Tortorella P; Rovaris M; Gasperini C; Montalban X; Geurts JJ; Polman CH; Barkhof F; Filippi M; Altmann DR; Ciccarelli O; Miller DH; Chard DT
    Mult Scler; 2014 Jan; 20(1):72-80. PubMed ID: 23812283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome.
    Brownlee WJ; Altmann DR; Alves Da Mota P; Swanton JK; Miszkiel KA; Wheeler-Kingshott CG; Ciccarelli O; Miller DH
    Mult Scler; 2017 Apr; 23(5):665-674. PubMed ID: 27481210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis.
    Lukas C; Knol DL; Sombekke MH; Bellenberg B; Hahn HK; Popescu V; Weier K; Radue EW; Gass A; Kappos L; Naegelin Y; Uitdehaag BM; Geurts JJ; Barkhof F; Vrenken H
    J Neurol Neurosurg Psychiatry; 2015 Apr; 86(4):410-8. PubMed ID: 24973341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper cervical cord atrophy is independent of cervical cord lesion volume in early multiple sclerosis: A two-year longitudinal study.
    Weeda MM; Zywicki S; Brouwer I; Moraal B; Killestein J; Gallo P; Barkhof F; Pouwels PJW; Vrenken H
    Mult Scler Relat Disord; 2022 Apr; 60():103713. PubMed ID: 35272146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2.
    Bakshi R; Neema M; Tauhid S; Healy BC; Glanz BI; Kim G; Miller J; Berkowitz JL; Bove R; Houtchens MK; Severson C; Stankiewicz JM; Stazzone L; Chitnis T; Guttmann CR; Weiner HL; Ceccarelli A
    Neuroreport; 2014 Oct; 25(14):1156-61. PubMed ID: 25100554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study.
    Hidalgo de la Cruz M; Valsasina P; Meani A; Gallo A; Gobbi C; Bisecco A; Tedeschi G; Zecca C; Rocca MA; Filippi M
    Mult Scler; 2022 Mar; 28(3):406-417. PubMed ID: 34124963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study.
    Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Barkhof F; Schoonheim MM; Strijbis EM; Vrenken H; Gallo A; Bisecco A; Ciccarelli O; Yiannakas M; Rovira A; Sastre-Garriga J; Palace J; Matthews L; Gass A; Eisele P; Lukas C; Bellenberg B; Margoni M; Preziosa P; Filippi M;
    J Neurol Neurosurg Psychiatry; 2023 Jan; 94(1):10-18. PubMed ID: 36171105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year study.
    Rashid W; Davies GR; Chard DT; Griffin CM; Altmann DR; Gordon R; Thompson AJ; Miller DH
    J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):51-5. PubMed ID: 16361592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upper cervical cord area in early relapsing-remitting multiple sclerosis: cross-sectional study of factors influencing cord size.
    Rashid W; Davies GR; Chard DT; Griffin CM; Altmann DR; Gordon R; Kapoor R; Thompson AJ; Miller DH
    J Magn Reson Imaging; 2006 Apr; 23(4):473-6. PubMed ID: 16521094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis.
    Kearney H; Schneider T; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):608-14. PubMed ID: 25097217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.